PCSA
Processa·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 2
Bearish signal 0
Stock Price Surged Significantly
Ample Liquidity
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About PCSA
Processa Pharmaceuticals, Inc.
A clinical stage biopharmaceutical company that develops products for cancers
Pharmaceutical
03/29/2011
10/02/2020
NASDAQ Stock Exchange
13
12-31
Common stock
7380 Coca Cola Drive, Suite 106, Hanover, Maryland 21076
--
Processa Pharmaceuticals, Inc., was founded on March 29, 2011. The company is a clinical-stage biopharmaceutical company focused on the development of pharmaceutical products designed to provide treatments and improve survival and quality of life for highly unsatisfied patients.
Company Financials
EPS
PCSA has released its 2025 Q3 earnings. EPS was reported at -0.07, versus the expected -0.08, beating expectations. The chart below visualizes how PCSA has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
